Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Pardoll

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
International Reviews of Immunology|December 16, 2006
GM-CSF gene-modifed cancer cell immunotherapies: of mice and menKristen M Hege, Karin Jooss, Drew Pardoll
Neurological Research|December 16, 2005
Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cellsMaciej S Lesniak, Erin Kelleher, Drew Pardoll, et al.
Cancer Research|April 20, 2011
A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumorsHeehyoung Lee, Jiehui Deng, Hong Xin, et al.
Blood|January 10, 2002
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cellsYan Cui, Jonathan Golob, Erin Kelleher, et al.
The Laryngoscope|August 5, 2003
Spatial distribution of tumor vaccine improves efficacyMarion Couch, John K Saunders, Bert W O'Malley, et al.
The Laryngoscope|March 5, 2003
Genetically engineered tumor cell vaccine in a head and neck cancer modelMarion Couch, John K Saunders, Bert W O'Malley, et al.
Blood|July 29, 2010
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myelomaKimberly Noonan, Luigi Marchionni, Judy Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2011
Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responsesMeghan B Davis, David Vasquez-Dunddel, Juan Fu, et al.
Cancer Research|May 10, 2014
Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumorsJuan Fu, Ian-James Malm, Deepak K Kadayakkara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
International Reviews of Immunology|December 16, 2006
GM-CSF gene-modifed cancer cell immunotherapies: of mice and menKristen M Hege, Karin Jooss, Drew Pardoll
Neurological Research|December 16, 2005
Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cellsMaciej S Lesniak, Erin Kelleher, Drew Pardoll, et al.
Cancer Research|April 20, 2011
A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumorsHeehyoung Lee, Jiehui Deng, Hong Xin, et al.
Blood|January 10, 2002
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cellsYan Cui, Jonathan Golob, Erin Kelleher, et al.
The Laryngoscope|August 5, 2003
Spatial distribution of tumor vaccine improves efficacyMarion Couch, John K Saunders, Bert W O'Malley, et al.
The Laryngoscope|March 5, 2003
Genetically engineered tumor cell vaccine in a head and neck cancer modelMarion Couch, John K Saunders, Bert W O'Malley, et al.
Blood|July 29, 2010
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myelomaKimberly Noonan, Luigi Marchionni, Judy Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2011
Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responsesMeghan B Davis, David Vasquez-Dunddel, Juan Fu, et al.
Cancer Research|May 10, 2014
Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumorsJuan Fu, Ian-James Malm, Deepak K Kadayakkara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsShiwen Peng, Cornelia Trimble, Lee Wu, et al.
Pageof 7